These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6703)

  • 1. Limiting factors in the antagonism of neuroleptics on dopamine-sensitive adenylate cyclase.
    Laduron P
    J Pharm Pharmacol; 1976 Mar; 28(3):250-1. PubMed ID: 6703
    [No Abstract]   [Full Text] [Related]  

  • 2. Tricyclic antidepressive drugs and dopamine-sensitive adenylate cyclase from rat brain striatum.
    Karobath ME
    Eur J Pharmacol; 1975 Feb; 30(2):159-63. PubMed ID: 1126356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain.
    Karobath M; Leitich H
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2915-8. PubMed ID: 4527668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the inhibitory effects of neuroleptic drugs on adenylate cyclase in rat tissues stimulated by dopamine, noradrenaline and glucagon.
    Miller RJ
    Biochem Pharmacol; 1976 Mar; 25(5):537-41. PubMed ID: 942490
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum.
    Miller RJ; Horn AS; Iversen LL
    J Pharm Pharmacol; 1975 Mar; 27(3):212-3. PubMed ID: 238011
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid.
    Thomas TN; Zemp JW
    J Neurochem; 1977 Mar; 28(3):663-5. PubMed ID: 853306
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.
    Honma T; Fukushima H
    Neuropharmacology; 1976 Oct; 15(10):601-7. PubMed ID: 1033478
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.
    Vonvoigtlander PF; Losey EG; Triezenberg HJ
    J Pharmacol Exp Ther; 1975 Apr; 193(1):88-94. PubMed ID: 166158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by beta-endorphin of dopamine-sensitive adenylate cyclase in rat striatum.
    Motomatsu T; Lis M; Seidah N; Chrétien M
    Biochem Biophys Res Commun; 1977 Jul; 77(1):442-7. PubMed ID: 883988
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats.
    Seeber U; Kuschinsky K
    Experientia; 1976 Dec; 32(12):1558-9. PubMed ID: 191279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism.
    Miller RJ; Hiley CR
    Nature; 1974 Apr; 248(449):596-7. PubMed ID: 4150951
    [No Abstract]   [Full Text] [Related]  

  • 13. The absence of sodium ions does not explain the failure of sulpiride to inhibit, in vitro, rat striatal dopamine-sensitive adenylate cyclase.
    Rupniak NM; Jenner P; Marsden CD
    J Pharm Pharmacol; 1981 Sep; 33(9):602-3. PubMed ID: 6117643
    [No Abstract]   [Full Text] [Related]  

  • 14. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
    Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
    Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
    [No Abstract]   [Full Text] [Related]  

  • 15. Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.
    Karobath ME
    Eur J Pharmacol; 1974 Oct; 28(2):376-8. PubMed ID: 4424404
    [No Abstract]   [Full Text] [Related]  

  • 16. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a connection between high affinity 3H-spiperone binding sites and DA-sensitive adenylate cyclase in corpus striatum?
    Marchais D; Bockaert J
    Biochem Pharmacol; 1980 May; 29(10):1331-6. PubMed ID: 7053066
    [No Abstract]   [Full Text] [Related]  

  • 18. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the accumulation of O-methylated dopamine and noradrenaline in the rat brain following various neuroleptics, thymoleptics and aceperone.
    Scheel-Krüger J
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):372-8. PubMed ID: 5015941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.